US 9555112
Monoclonal antibodies against HER2 epitope and methods of use thereof
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9555112 (Monoclonal antibodies against HER2 epitope and methods of use thereof) held by Mersana Therapeutics, Inc. expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Mersana Therapeutics, Inc.
- Grant date
- Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K38/08, A61K45/06